Astrela Moore, PharmD, BCPPS
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Skip to content
Pharmacy Practice (PGY1) – The Johns Hopkins Hospital, Baltimore, MD
Basic Life Support (BLS)Board Certified Pediatric Pharmacy Specialist (BCPPS)Pediatric Advanced Life Support (PALS)
PharmD - Rutgers University, New Brunswick, NJ
Clinical Pharmacy Specialist, General Pediatrics
Residency Preceptor, Pharmacy Residency Program
Rudra S, Shaul E, Conrad M, Patel T, Moore A, Dawany N, Canavan MC, Sullivan KE, Behrens E, Kelsen JR. Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2021 Jul 27:S1542-3565(21)00822-3
Galligan M, Rojas C, Ehritz C, Moore, A, Flynn, E, Khan A, Becker E, Harris T, Hart J. Improving Medication Route Errors in Children with Enteral Tube Dependence. Platform presentation at: Pediatric Academic Societies Meeting. Philadelphia, PA. May 2021.
Galligan M, Moore, A, Rojas C, Coffin A, McClam C, Flynn E, Ehritz C, Hart J. Implementation of a Weekly, Pharmacy-led Medication Rounding Process on an Inpatient Complex Care Service. Poster presentation at: Academic Pediatric Association 10th Annual Conference on Advancing Quality Improvement Science for Children’s Health Care. April 2021.
Rudra S, Shaul E, Moore A, Conrad M, Kelsen J. Application of a Selective JAK1/JAK2 inhibitor in Hyperinflammatory VEO-IBD Phenotype. Poster presentation at: North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Annual Meeting. October 2020.
American Society of Health-System Pharmacists (ASHP)
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.